COVID-19患者を対象としたS-892216の研究
基本情報
- NCT ID
- NCT06928051
- ステータス
- 完了
- 試験のフェーズ
- 第2相
- 試験タイプ
- 介入
- 目標被験者数
- 282
- 治験依頼者名
- Shionogi Inc.
概要
The primary objective of this study is to investigate the antiviral effect of S-892216 in participants with coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
対象疾患
介入
依頼者（Sponsor）
実施施設 (36)
Japanese Site 9
Multiple Locations, Japan
Japanese Site 8
Multiple Locations, Japan
Japanese Site 36
Multiple Locations, Japan
Japanese Site 15
Multiple Locations, Japan
Japanese Site 2
Multiple Locations, Japan
Japanese Site 1
Multiple Locations, Japan
Japanese Site 4
Multiple Locations, Japan
Japanese Site 22
Multiple Locations, Japan
Japanese Site 11
Multiple Locations, Japan
Japanese Site 34
Multiple Locations, Japan
Japanese Site 16
Multiple Locations, Japan
Japanese Site 24
Multiple Locations, Japan
Japanese Site 10
Multiple Locations, Japan
Japanese Site 21
Multiple Locations, Japan
Japanese Site 18
Multiple Locations, Japan
Japanese Site 20
Multiple Locations, Japan
Japanese Site 32
Multiple Locations, Japan
Japanese Site 27
Multiple Locations, Japan
Japanese Site 3
Multiple Locations, Japan
Japanese Site 26
Multiple Locations, Japan
Japanese Site 14
Multiple Locations, Japan
Japanese Site 13
Multiple Locations, Japan
Japanese Site 17
Multiple Locations, Japan
Japanese Site 7
Multiple Locations, Japan
Japanese Site 30
Multiple Locations, Japan
Japanese Site 28
Multiple Locations, Japan
Japanese Site 25
Multiple Locations, Japan
Japanese Site 12
Multiple Locations, Japan
Japanese Site 33
Multiple Locations, Japan
Japanese Site 5
Multiple Locations, Japan
Japanese Site 35
Multiple Locations, Japan
Japanese Site 6
Multiple Locations, Japan
Japanese Site 19
Multiple Locations, Japan
Japanese Site 31
Multiple Locations, Japan
Japanese Site 23
Multiple Locations, Japan
Japanese Site 29
Multiple Locations, Japan